Chatham Township, NJ, United States of America

Andrew William Stamford

Average Co-Inventor Count = 5.5

ph-index = 13

Forward Citations = 709(Granted Patents)

Forward Citations (Not Self Cited) = 542(Sep 21, 2024)

DiyaCoin DiyaCoin 0.57 

Inventors with similar research interests:


Location History:

  • Chatham Twp., NJ (US) (1995)
  • Kenilworth, NJ (US) (2012 - 2013)
  • Rahway, NJ (US) (2015)
  • Chatham Township, NJ (US) (2001 - 2016)
  • Chatham, NJ (US) (2005 - 2021)
  • Morristown, NJ (US) (2021)


Years Active: 1995-2021

where 'Filed Patents' based on already Granted Patents

125 patents (USPTO):
8 patents (CIPO):

Title: Andrew William Stamford: A Pioneering Inventor in the Field of Pharmaceuticals

Introduction:

In the world of pharmaceutical innovation, there are individuals who dedicate their lives to research and development, pushing the boundaries of science to create groundbreaking treatments. Andrew William Stamford is one such inventor, whose ingenuity has led to significant advancements in the field. This article delves into his latest patents, career highlights, collaborations, and showcases his contributions to the world of pharmaceuticals.

Latest Patents:

Andrew William Stamford has an impressive record, with a total of 123 patents to his name. His recent patents highlight his expertise in developing compounds that inhibit leucine-rich repeat kinase (LRRK2), a significant enzyme associated with Parkinson's Disease.

One of his latest patents involves substituted reversed indazole compounds, known as Formula (I), which have proven to be potent inhibitors of LRRK2 kinase. These compounds show great potential in the treatment and prevention of diseases involving LRRK2 kinase, such as Parkinson's Disease. Stamford's invention also includes the development of pharmaceutical compositions containing these compounds for effective disease management.

Another noteworthy patent by Stamford involves substituted aminoquinazoline compounds that act as A-receptor antagonists. These compounds have promising therapeutic potential in treating diseases or disorders associated with A-receptor involvement, including central nervous system disorders such as Parkinson's Disease. Pharmaceutical compositions containing these compounds have also been developed for the treatment and prevention of such diseases.

Career Highlights:

Throughout his illustrious career, Stamford has made a significant impact on the pharmaceutical industry. He has worked in esteemed companies like Merck Sharp & Dohme Corporation and Schering Corporation, where he has played a pivotal role in driving innovation and discovering groundbreaking solutions.

Collaborations:

Stamford has collaborated with various talented individuals in his quest for pharmaceutical advancements. Notable among his coworkers are Jared N. Cumming and Ulrich Iserloh. These collaborations have allowed for the exchange of ideas and expertise, fostering a culture of innovation and ultimately leading to impactful inventions.

Conclusion:

Andrew William Stamford's contributions in the field of pharmaceutical research and development have been commendable. With an extensive patent portfolio and a concentration on discovering potent inhibitors and treatments for diseases like Parkinson's Disease, his work has the potential to make a remarkable difference in patients' lives worldwide. His collaboration with talented colleagues further highlights his commitment to achieving groundbreaking advancements in the pharmaceutical industry. Andrew William Stamford continues to inspire fellow inventors and researchers to push the boundaries of innovation for the betterment of society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…